Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
K36 Therapeutics, Inc.
M.D. Anderson Cancer Center
Atavistik Bio, Inc
M.D. Anderson Cancer Center
AgonOx, Inc.
Eli Lilly and Company
Advanced Accelerator Applications
Endocyte
Poseida Therapeutics, Inc.
Advaxis, Inc.
Aragon Pharmaceuticals, Inc.
Mayo Clinic
Virginia Commonwealth University
IGF Oncology, LLC
sigma-tau i.f.r. S.p.A.
Celldex Therapeutics
Celldex Therapeutics
Merck Sharp & Dohme LLC
Tesaro, Inc.
Pharmacyclics LLC.